A phase 3 trial of Johnson & Johnson's TAR-200 therapy in bladder cancer has failed to show efficacy, although the company is still confident in the potential of the programme. The SunRISe-2 study, in ...
The Baylor College of Medicine Clinical Psychology Ph.D. program is hosting virtual information sessions in October and November. This is an opportunity to learn about the program and ask questions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback